BW

Brian John Williams

Merck: 46 patents #127 of 9,382Top 2%
AL Astex Therapeutics Limited: 5 patents #50 of 199Top 30%
CI Ciba-Geigy: 1 patents #1,572 of 2,867Top 55%
Overall (All Time): #51,144 of 4,157,543Top 2%
52
Patents All Time

Issued Patents All Time

Showing 26–50 of 52 patents

Patent #TitleCo-InventorsDate
6071927 Spiro-piperidine derivatives and their use as therapeutic agents Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +4 more 2000-06-06
6060469 Spiro-piperidine derivatives and their use as tachykinin antagonists Raymond Baker, Timothy Harrison, Christopher John Swain 2000-05-09
6048859 Morpholine and thiomorpholine tachykinin receptor antagonists Conrad P. Dorn, Paul E. Finke, Jeffrey J. Hale, Malcolm MacCoss, Sander G. Mills +4 more 2000-04-11
5985874 Substituted morpholine derivative and its use as a therapeutic agent Simon Owen, Christopher John Swain 1999-11-16
5977104 Use of NK-1 receptor antagonists for treating bipolar disorders Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 1999-11-02
5968934 Morpholine derivatives and their use as therapeutic agents Christopher John Swain, Martin Teall 1999-10-19
5952315 Use of NK-1 receptor antagonists for treating bipolar disorders Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 1999-09-14
5929054 Use of NK-1 receptor antagonists for treating sexual dysfunctions Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 1999-07-27
5925627 Use of NK-1 receptor antagonists for treating movement disorders Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 1999-07-20
5919781 Use of NK-1 receptor antogonists for treating substance use disorders Raymond Baker, Neil Roy Curtis, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth +5 more 1999-07-06
5872116 Morpholine and thiomorpholine tachykinin receptor antagonists Conrad P. Dorn, Paul E. Finke, Jeffrey J. Hale, Malcolm MacCoss, Sander G. Mills +4 more 1999-02-16
5719147 Morpholine and thiomorpholine tachykinin receptor antagonists Conrad P. Dorn, Paul E. Finke, Jeffrey J. Hale, Malcolm MacCoss, Sander G. Mills +4 more 1998-02-17
5637699 Process for preparing morpholine tachykinin receptor antagonists Conrad P. Dorn, Jeffrey J. Hale, Paul E. Finke, Malcolm MacCoss, Sander G. Mills +4 more 1997-06-10
5633266 Azacyclic compounds compositions containing them and their use as tachykinin antagonists Raymond Baker, Christopher John Swain 1997-05-27
5633281 3,3-diphenyl prop-2-yl amino acid derivatives and their use as tachykinin antagonists Martin Teall 1997-05-27
5629347 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy Christopher John Swain, Martin Teall 1997-05-13
5620989 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits Timothy Harrison, Angus Murray MacLeod, Graeme Irvine Stevenson 1997-04-15
5610159 N-oxides of morpholine derivatives and their use as therapeutic agents Jonathan Moseley, Christopher John Swain 1997-03-11
5610183 Phenylglycine derivatives pharmaceutical compositions containing them and their use in therapy Andrew Pate Owens 1997-03-11
5494926 2/3-(heterocyclic alkyl amino)-1-(subst.-phenyl-methoxy)-ethanes/propanes as tachykinin-receptor antagonists Andrew Pate Owens, Martin Teall 1996-02-27
5495047 Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy Monique Bodil Van Niel, Walfred S. Saari 1996-02-27
5459270 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them Raymond Baker, Timothy Harrison, Christopher John Swain 1995-10-17
5331089 Peptides useful as tachykinin agonists Neil Roy Curtis 1994-07-19
5288730 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy Raymond Baker, Christopher John Swain, Martin Teall 1994-02-22
5166350 Process for the manufacture of fluoran compounds Davor Bedekovic, Jerry L. Pool, Robert Garner, John Barry Henshall 1992-11-24